By Colin Kellaher

Dentsply Sirona said it won't reinstate at-home sales of its Byte dental aligner systems and impression kits, opting to refocus the Byte business model around treatments that include expanded in-person dentist oversight.

Dentsply, which in October suspended sales and marketing of the Byte products while it conducted a review of certain regulatory requirements, on Tuesday said it expects the move to result in potentially material impacts on its fourth-quarter results, including an estimate for customer refunds and possible asset write-offs.

Dentsply in October had warned that the decision to suspend Byte sales, which it made in consultation with the Food and Drug Administration, would have a material impact on its results, as sales of the products represent roughly 5% of its annual revenue.

The Charlotte, N.C., company on Tuesday said it will provide more information on the refunds and write-offs during its fourth-quarter earnings call.

Dentsply also said it will continue to provide support for non-contraindicated Byte aligner patients currently undergoing treatment.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

January 14, 2025 08:51 ET (13:51 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.